Clinical Trial Update: Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing capecitabine with or without oxaliplatin to cisplatin-5-FU for esophageal squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Cisplatin-5-FU (cisplatin-5-FU)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Stage III Esophageal Squamous Cell Carcinoma, Stage II Esophageal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN